fluorouracil has been researched along with meriolin 3 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aruri, H; Bharate, SS; Bhushan, S; Chashoo, G; Chibber, P; Guru, SK; Khan, SU; Kumar, V; Madishetti, S; Mahajan, G; Mahajan, P; Malik, F; Mignani, S; Mintoo, MJ; Mir, SA; Mondhe, DM; Nandi, U; Nargotra, A; Sahu, P; Sharma, A; Singh, A; Singh, G; Singh, PP; Singh, U; Thatikonda, T; Vishwakarma, RA | 1 |
1 other study(ies) available for fluorouracil and meriolin 3
Article | Year |
---|---|
Design of Novel 3-Pyrimidinylazaindole CDK2/9 Inhibitors with Potent In Vitro and In Vivo Antitumor Efficacy in a Triple-Negative Breast Cancer Model.
Topics: Animals; Antineoplastic Agents; Breast; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 9; Drug Screening Assays, Antitumor; Female; Humans; Indoles; Mice; Mice, Inbred BALB C; Protein Kinase Inhibitors; Pyrimidines; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2017 |